ES2063432T3 - Compuestos farmaceuticos orales de dosis unitaria. - Google Patents

Compuestos farmaceuticos orales de dosis unitaria.

Info

Publication number
ES2063432T3
ES2063432T3 ES91200029T ES91200029T ES2063432T3 ES 2063432 T3 ES2063432 T3 ES 2063432T3 ES 91200029 T ES91200029 T ES 91200029T ES 91200029 T ES91200029 T ES 91200029T ES 2063432 T3 ES2063432 T3 ES 2063432T3
Authority
ES
Spain
Prior art keywords
unit dose
oral pharmaceutical
pharmaceutical compounds
oral
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91200029T
Other languages
English (en)
Inventor
Jan Willem Groenendaal
Aart Muhlenbruch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BROCADES PHARMA BV
Original Assignee
BROCADES PHARMA BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BROCADES PHARMA BV filed Critical BROCADES PHARMA BV
Application granted granted Critical
Publication of ES2063432T3 publication Critical patent/ES2063432T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SON UNOS COMPUESTOS FARMACOLOGICOS POR VIA ORAL EN UNA DOSIS, ESPECIALMENTE EN FORMA DE CAPSULAS, QUE CONSTAN DE UN COMPUESTO SOLIDO DE SUBCITRATO DE BISMUTO COLOIDAL (SBC), QUE PUEDEN LLEVAR EN ALGUNOS CASOS UNO O MAS MEDICAMENTOS Y EXCIPIENTES, LAS DOSIS TIENEN UNA DENSIDAD DE EMBALAJE DE ENTRE 0.06 Y 0.60 GRAMOS DE SBC POR CADA MILILITRO.
ES91200029T 1990-01-09 1991-01-09 Compuestos farmaceuticos orales de dosis unitaria. Expired - Lifetime ES2063432T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90200064 1990-01-09

Publications (1)

Publication Number Publication Date
ES2063432T3 true ES2063432T3 (es) 1995-01-01

Family

ID=8204917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91200029T Expired - Lifetime ES2063432T3 (es) 1990-01-09 1991-01-09 Compuestos farmaceuticos orales de dosis unitaria.

Country Status (18)

Country Link
US (1) US5264222A (es)
EP (1) EP0437294B1 (es)
KR (1) KR910014124A (es)
AT (1) ATE101039T1 (es)
AU (1) AU638083B2 (es)
CA (1) CA2033870A1 (es)
DE (1) DE69101111T2 (es)
DK (1) DK0437294T3 (es)
ES (1) ES2063432T3 (es)
FI (1) FI910088A7 (es)
HU (1) HU204707B (es)
IE (1) IE910057A1 (es)
IL (1) IL96904A0 (es)
MY (1) MY106371A (es)
NO (1) NO910080L (es)
NZ (1) NZ236721A (es)
PT (1) PT96437A (es)
ZA (1) ZA91178B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
ES2267108T3 (es) * 1995-08-24 2007-03-01 Josman Laboratories, Inc. Composiciones que contienen bismuto en formas de dosificacion topicas.
WO1998022117A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
EP0941102A1 (en) * 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
WO2021072350A1 (en) * 2019-10-11 2021-04-15 Tobebio Novel Drug Co., Ltd. Synergistic combination of chemotherapy and peptide for treating cancer
CN111214443A (zh) * 2020-02-23 2020-06-02 北京鑫开元医药科技有限公司 一种枸橼酸铋钾颗粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4670245A (en) * 1984-04-27 1987-06-02 Vasquez Tony E Diagnostic procedures using radiolabeled colloidal bismuth subcitrate and related compounds
CA1207239A (en) * 1984-08-10 1986-07-08 Upendra K. Banik Gastrointestinal compositions
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
GB8612401D0 (en) * 1986-05-21 1986-06-25 Evode Ltd Liquid polmers
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines

Also Published As

Publication number Publication date
PT96437A (pt) 1991-10-15
HU204707B (en) 1992-02-28
AU638083B2 (en) 1993-06-17
IL96904A0 (en) 1992-03-29
NO910080L (no) 1991-07-10
EP0437294B1 (en) 1994-02-02
NO910080D0 (no) 1991-01-08
DK0437294T3 (da) 1994-03-07
CA2033870A1 (en) 1991-07-10
KR910014124A (ko) 1991-08-31
NZ236721A (en) 1992-08-26
MY106371A (en) 1995-05-30
EP0437294A1 (en) 1991-07-17
ATE101039T1 (de) 1994-02-15
ZA91178B (en) 1991-10-30
DE69101111T2 (de) 1994-07-28
FI910088L (fi) 1991-07-10
FI910088A7 (fi) 1991-07-10
FI910088A0 (fi) 1991-01-07
US5264222A (en) 1993-11-23
DE69101111D1 (de) 1994-03-17
IE910057A1 (en) 1991-07-17
AU6869391A (en) 1991-07-11

Similar Documents

Publication Publication Date Title
ES2063432T3 (es) Compuestos farmaceuticos orales de dosis unitaria.
IT8921132A0 (it) Inalatore per medicamenti in capsule.
CO4560547A1 (es) Una forma de dosis de azitromicina y un metodo de trata- miento de una infeccion microbiana que involucra la adminis- tracion de azitromicina
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
DK1207809T3 (da) Dosering og emballering af mediciner med kontrolleret frisætning
DE58901934D1 (de) Verschlussanordnung fuer pharmazeutische flaschen.
IT1231399B (it) Macchine di riempimento e chiusura per capsule in due parti.
FI924247A7 (fi) Annostusmuoto lääkkeen vapauttamiseksi suoleen
NO912607D0 (no) Oral, fast farmasoeytisk doseringsform med programmert frigivelse.
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
DE69310887D1 (de) Pharmazeutische behälter und medizinische geräte mit hydrophilen, proteinverträglichen oberflächen
DE69133371D1 (de) Pharmazeutische wirksame Benzochinazolin Verbindungen
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
DE59506611D1 (de) Befüllung von pharmazeutischen mehrkammerverpackungen
DK392288A (da) Human monoklonale antistoffer samt profylaktiske og terapeutiske midler mod infrektioese sygdomme, der indeholder samme som aktiv bestanddel
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
ITTO930474A1 (it) Dispositivo di diluizione di una soluzione in un flacone, per la dinamizzazione di medicine omeopatiche
IT238786Y1 (it) Contenitore distributore, specialmente per prodotti medicianali in compresse o capsule e simili.
RU97119670A (ru) Способ профилактики иксодовых клещевых боррелиозов